VPHIF Dividend: Valeo Pharma Inc Yield Insights

根据最新的财务报表（Form-10K），Valeo Pharma Inc 的总资产为 $41，净loss为 $-27

Valeo Pharma Inc 的流动比率是 0.5，净利 margin 为 -50.94，每股销售为 $0.61。

Currently Valeo Pharma Inc data is not available.

no，根据最新的财务报表，Valeo Pharma Inc 的净loss为 $-27

yes，Valeo Pharma Inc 的负债为 81

Valeo Pharma Inc 的总流通股为 98.63

Income

Balance sheet

Cash flow

Annual

Quarterly

VPHIF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019
Revenue	53	53	27	13	7	6
Revenue Growth (YoY)	0%	96%	108%	86%	17%	50%
Cost of Revenue	44	40	21	9	6	5
Gross Profit	8	13	6	3	1	1
Selling, General & Admin	27	29	25	16	5	5
Research & Development	--	--	--	--	0	0
Operating Expenses	27	30	25	16	5	5
Other Non Operating Income (Expenses)	4	2	0	0	0	0
Pretax Income	-32	-27	-26	-14	-4	-3
Income Tax Expense	--	0	-1	0	0	0
Net Income	-32	-27	-25	-14	-4	-3
Net Income Growth	14%	8%	79%	250%	33%	50%
Shares Outstanding (Diluted)	98.67	86.11	80.85	69.93	57.9	49.58
Shares Change (YoY)	17%	7%	16%	21%	17%	39%
EPS (Diluted)	-0.34	-0.32	-0.31	-0.2	-0.08	-0.07
EPS Growth	-1%	1%	56%	148%	13%	7%
Free Cash Flow	-9	-21	-35	-15	-6	-3
Free Cash Flow Per Share	-0.09	-0.24	-0.43	-0.21	-0.1	-0.06
Gross Margin	15.09%	24.52%	22.22%	23.07%	14.28%	16.66%
Operating Margin	-35.84%	-32.07%	-70.37%	-92.3%	-57.14%	-50%
Profit Margin	-60.37%	-50.94%	-92.59%	-107.69%	-57.14%	-50%
Free Cash Flow Margin	-16.98%	-39.62%	-129.62%	-115.38%	-85.71%	-50%
EBITDA	-17	-15	-18	-12	-4	-3
EBITDA Margin	-32.07%	-28.3%	-66.66%	-92.3%	-57.14%	-50%
D&A For EBITDA	2	2	1	0	0	0
EBIT	-19	-17	-19	-12	-4	-3
EBIT Margin	-35.84%	-32.07%	-70.37%	-92.3%	-57.14%	-50%
Effective Tax Rate	--	0%	3.84%	0%	0%	0%